Genesis Therapeutics

Genesis Therapeutics Rakes In $200M For AI-Powered Drug Discovery

Genesis Therapeutics recently joined the growing list of AI-powered drug discovery startups receiving venture funding this year. The company closed a $200 million Series B financing round, taking its total funding to date to more than $280 million.

By Katie Adams

Artificial Intelligence, BioPharma

AI drug discovery firm spins out of Stanford research

Another AI drug discovery firm has sprung up in Silicon Valley with seed investors, including Andreessen Horowitz, kicking in $4.1 million.

By Joel Berg

Artificial Intelligence

What Keeps Healthcare CIOs Up at Night: Balancing Technology Investments with Consumer Expectations

When it comes to managing inbound phone calls, underperformance has devastating cost implications.

By Stephanie Baum

Tips for Greater Healthcare Practice Success in 2025

Join us on February 26 at 3 pm ET, and we’ll dive into the key areas where practices are losing time and money and provide solutions to overcome them.

By Elation Health and MedCity News

Healthcare

Using Data to Help Healthcare Practices Succeed

A new report from Relatient, A Data-Driven Guide to Patient Access Succes, highlights how focusing on data accuracy and relevance can enhance the performance of healthcare practices.

By Relatient